Synthesis and chemistry of unusual bicyclic endoperoxides containing the pyridazine ring

Journal of Organic Chemistry

Volumn 68, Issue 18, 2003, Pages 7009-7015

  Özer, Galip ^a   Saraçoǧlu, Nurullah ^a   Balci, Metin ^b  

^a ATATÜRK UNIVERSITY   (Turkey)

^b MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYSIS; PHASE TRANSITIONS; SYNTHESIS (CHEMICAL);

PEROXIDE LINKAGES;

ORGANIC COMPOUNDS;

BICYCLIC ENDOPEROXIDE; CARBOXYLIC ACID DERIVATIVE; DIMETHYL 1,2,4,5 TETRAZINE 3,6 DICARBOXYLATE; DIMETHYL 10,11 DIOXA 4,5 DIAZATRICYCLO[7.2.2.0 2,7]TRIDECA 2,4,6 TRIENE 3,6 DICARBOXYLATE; DIMETHYL 12,13 DIOXA 4,5 DIAZATRICYCLO[6.3.2.0 2,7]TRIDECA 2,4,6 TRIENE 3,6 DICARBOXYLATE; DIMETHYL 12,13 DIOXA 4,5 DIAZATRICYCLO[6.3.2.0 2,7]TRIDECA 2,5 DIENE 3,6 DICARBOXYLATE; DIMETHYL 12,13 DIOXA 4,5 DIAZATRICYCLO[6.3.2.0 2,7]TRIDECA 2,5,9 TRIENE 3,6 DICARBOXYLATE; ENDOPEROXIDE; KETOL; PHTHALAZINE 5,8 DIONE; PYRIDAZINE DERIVATIVE; TETRAPHENYLPORPHYRIN DERIVATIVE; THIOUREA DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; DRUG STRUCTURE; DRUG SYNTHESIS; REACTION ANALYSIS; STRUCTURE ANALYSIS;

EID: 18844463439     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo0345300     Document Type: Article

References (53)

1. (a) Pal, M.; Batchu, V. R.; Khanna, S.; Yeleswarapu K. R. Tetrahedron 2002, 58, 9933-9940.
2. (b) Tisler, M.; Stanovnik B. In Heterocyclic Chemistry; Katritzky, A. R., Ed.; Academic: San Diego, 1990; Vol. 49, p 1.
3. (c) Coates, W. J.; McKillop A. Synthesis 1993, 334-342.
4. (a) Heinisch, G.; Kopelent H. In Progress in Medicinal Chemistry; Ellis, G. P., West, G. B., Eds.; Elsevier: Amsterdam, 1992; Vol. 29, p 141.
5. (b) Ungureanu M.; Mangalagiu I.; Grosu, G.; Petrovanu M. Ann. Pharm. Fr. 1997, 55, 2-69.
6. (a) Pita, B.; Sotelo, E.; Saurez M.; Ravina, E.; Ochoa E.; Verdecia, Y.; Novoa, H.; Blaton, N.; de Ranter, C. Peeters O. M., Tetrahedron 2000, 56, 2473-2479.
7. (b) Campos, M.; Estevez, I.; Ravina, E.; Orallo, F. Gen. Pharmacol. 1998, 30, 201-207.
8. (a) Donkers, R. L.; Workentin, M. S. Chem. Eur. J. 2001, 7, 4012-4020.
9. (b) Clennan, E. L.; Foote C. S. In Organic Peroxides; Ando W., Ed.; Wiley: Chichester, England, 1992; p 225.
10. (c) Casteel D. A. Nat. Prod. Rep. 1999, 16, 55-73.
11. Balci M. Chem. Rev. 1981, 81, 91-108.
12. (a) Wu, Y.; Zheng, Y. Y.; Wu, Y.-L. Angew. Chem. 1999, 111, 2730-2733; Angew. Chem., Int. Ed. 1999, 38, 2580-2582.
13. (a) Wu, Y.; Zheng, Y. Y.; Wu, Y.-L. Angew. Chem. 1999, 111, 2730-2733; Angew. Chem., Int. Ed. 1999, 38, 2580-2582.
14. (b) Robert, A.; Meunier, B. Chem. Eur. J. 1998, 4, 1287-1296.
15. (c) O'Neill, P. M.; Bishop, L. P.; Searle, N. J.; Maggs, J. L.; Ward, S. A.; Bray, P. G.; Storr, R. C.; Park, B. K. Tetrahedron Lett. 1997, 38, 4263-4266.
16. For a short communication see: Balci, M.; Saraçoǧlu, N.; Menzek, A. Tetrahedron Lett. 1996, 37, 921-924.
17. For a review, see: (a) Dale, L.; Boger, D. L. Tetrahedron 1983, 39, 2869-2939.
18. (b) Sauer, J. 1,2,4,5-Tetrazines. In Comprehensive Heterocyclic Chemistry II; Katritzky, A. R., Rees, C. W., Scriven, E. F., Eds.; Pergamon Press, Oxford, 1996; Vol. 6, pp 901-957.
19. (a) Hayakawa, K.; Aso, M.; Kanematsu, K. J. Org. Chem. 1985, 50, 2036-2040.
20. (b) Tamura, Y.; Yakura, T.; Tohma, H.; Kihuchi, K.; Kita, Y. Synthesis, 1989, 126-127.
21. (c) Varvoglis, A. Tetrahedron 1997, 53, 1179-1255.
22. For phthalazine and their biological importance, see: (a) Gilchrist, T. L. Heterocyclic Chemistry, 3rd ed.; Longmans: Oxford, 1997. (b) Tsoungas, P. G. ; Searcey, M. Tetrahedron Lett. 2001, 42, 6589-6592. (c) Brzezinski, J. Z.; Browski, H. B.; Epsztajn, J. Tetrahedron 1996, 52, 3261-3272. (d) Eguchi, Y.; Sasaki, F.; Takashima, Y.; Nakajima, M.; Ishikawa, M. Chem. Pharm. Bull. 1991, 39, 795. (e) Cherkez, S.; Herzig, J.; Yellin, H. J. Med. Chem. 1986, 29, 947. (f) Scheffler, G.; Engel, J.; Kutscher, B.; Sheldrick, W. S.; Bell, P. Arch. Pharm. (Weinheim) 1988, 321, 205. (g) Yamaguchi, M.; Kamei, K.; Koga, T.; Akima, M.; Kuroki, T.; Ohi, N. J. Med. Chem. 1993, 36, 4052. (h) Bavin, E. M.; Drain, D. J.; Seiler, M.; Seymour, D. E. J. Pharm. Pharmacol. 1952, 4, 844. (i) Sugimoto A.; Tanaka, H.; Eguchi, Y.; Ito, S.; Takashima, Y.; Ishikawa, M. J. Med. Chem. 1984, 27, 1300. (j) Mylari, B. L.; Beyer, T. A.; Scott, P. J.; Aldinger, C. E.; Dee, M. F.; Siegel, T. W.; Zembrowski, J. J. Med. Chem. 1992, 35, 457.
23. For phthalazine and their biological importance, see: (a) Gilchrist, T. L. Heterocyclic Chemistry, 3rd ed.; Longmans: Oxford, 1997. (b) Tsoungas, P. G. ; Searcey, M. Tetrahedron Lett. 2001, 42, 6589-6592. (c) Brzezinski, J. Z.; Browski, H. B.; Epsztajn, J. Tetrahedron 1996, 52, 3261-3272. (d) Eguchi, Y.; Sasaki, F.; Takashima, Y.; Nakajima, M.; Ishikawa, M. Chem. Pharm. Bull. 1991, 39, 795. (e) Cherkez, S.; Herzig, J.; Yellin, H. J. Med. Chem. 1986, 29, 947. (f) Scheffler, G.; Engel, J.; Kutscher, B.; Sheldrick, W. S.; Bell, P. Arch. Pharm. (Weinheim) 1988, 321, 205. (g) Yamaguchi, M.; Kamei, K.; Koga, T.; Akima, M.; Kuroki, T.; Ohi, N. J. Med. Chem. 1993, 36, 4052. (h) Bavin, E. M.; Drain, D. J.; Seiler, M.; Seymour, D. E. J. Pharm. Pharmacol. 1952, 4, 844. (i) Sugimoto A.; Tanaka, H.; Eguchi, Y.; Ito, S.; Takashima, Y.; Ishikawa, M. J. Med. Chem. 1984, 27, 1300. (j) Mylari, B. L.; Beyer, T. A.; Scott, P. J.; Aldinger, C. E.; Dee, M. F.; Siegel, T. W.; Zembrowski, J. J. Med. Chem. 1992, 35, 457.
24. For phthalazine and their biological importance, see: (a) Gilchrist, T. L. Heterocyclic Chemistry, 3rd ed.; Longmans: Oxford, 1997. (b) Tsoungas, P. G. ; Searcey, M. Tetrahedron Lett. 2001, 42, 6589-6592. (c) Brzezinski, J. Z.; Browski, H. B.; Epsztajn, J. Tetrahedron 1996, 52, 3261-3272. (d) Eguchi, Y.; Sasaki, F.; Takashima, Y.; Nakajima, M.; Ishikawa, M. Chem. Pharm. Bull. 1991, 39, 795. (e) Cherkez, S.; Herzig, J.; Yellin, H. J. Med. Chem. 1986, 29, 947. (f) Scheffler, G.; Engel, J.; Kutscher, B.; Sheldrick, W. S.; Bell, P. Arch. Pharm. (Weinheim) 1988, 321, 205. (g) Yamaguchi, M.; Kamei, K.; Koga, T.; Akima, M.; Kuroki, T.; Ohi, N. J. Med. Chem. 1993, 36, 4052. (h) Bavin, E. M.; Drain, D. J.; Seiler, M.; Seymour, D. E. J. Pharm. Pharmacol. 1952, 4, 844. (i) Sugimoto A.; Tanaka, H.; Eguchi, Y.; Ito, S.; Takashima, Y.; Ishikawa, M. J. Med. Chem. 1984, 27, 1300. (j) Mylari, B. L.; Beyer, T. A.; Scott, P. J.; Aldinger, C. E.; Dee, M. F.; Siegel, T. W.; Zembrowski, J. J. Med. Chem. 1992, 35, 457.
25. For phthalazine and their biological importance, see: (a) Gilchrist, T. L. Heterocyclic Chemistry, 3rd ed.; Longmans: Oxford, 1997. (b) Tsoungas, P. G. ; Searcey, M. Tetrahedron Lett. 2001, 42, 6589-6592. (c) Brzezinski, J. Z.; Browski, H. B.; Epsztajn, J. Tetrahedron 1996, 52, 3261-3272. (d) Eguchi, Y.; Sasaki, F.; Takashima, Y.; Nakajima, M.; Ishikawa, M. Chem. Pharm. Bull. 1991, 39, 795. (e) Cherkez, S.; Herzig, J.; Yellin, H. J. Med. Chem. 1986, 29, 947. (f) Scheffler, G.; Engel, J.; Kutscher, B.; Sheldrick, W. S.; Bell, P. Arch. Pharm. (Weinheim) 1988, 321, 205. (g) Yamaguchi, M.; Kamei, K.; Koga, T.; Akima, M.; Kuroki, T.; Ohi, N. J. Med. Chem. 1993, 36, 4052. (h) Bavin, E. M.; Drain, D. J.; Seiler, M.; Seymour, D. E. J. Pharm. Pharmacol. 1952, 4, 844. (i) Sugimoto A.; Tanaka, H.; Eguchi, Y.; Ito, S.; Takashima, Y.; Ishikawa, M. J. Med. Chem. 1984, 27, 1300. (j) Mylari, B. L.; Beyer, T. A.; Scott, P. J.; Aldinger, C. E.; Dee, M. F.; Siegel, T. W.; Zembrowski, J. J. Med. Chem. 1992, 35, 457.
26. For phthalazine and their biological importance, see: (a) Gilchrist, T. L. Heterocyclic Chemistry, 3rd ed.; Longmans: Oxford, 1997. (b) Tsoungas, P. G. ; Searcey, M. Tetrahedron Lett. 2001, 42, 6589-6592. (c) Brzezinski, J. Z.; Browski, H. B.; Epsztajn, J. Tetrahedron 1996, 52, 3261-3272. (d) Eguchi, Y.; Sasaki, F.; Takashima, Y.; Nakajima, M.; Ishikawa, M. Chem. Pharm. Bull. 1991, 39, 795. (e) Cherkez, S.; Herzig, J.; Yellin, H. J. Med. Chem. 1986, 29, 947. (f) Scheffler, G.; Engel, J.; Kutscher, B.; Sheldrick, W. S.; Bell, P. Arch. Pharm. (Weinheim) 1988, 321, 205. (g) Yamaguchi, M.; Kamei, K.; Koga, T.; Akima, M.; Kuroki, T.; Ohi, N. J. Med. Chem. 1993, 36, 4052. (h) Bavin, E. M.; Drain, D. J.; Seiler, M.; Seymour, D. E. J. Pharm. Pharmacol. 1952, 4, 844. (i) Sugimoto A.; Tanaka, H.; Eguchi, Y.; Ito, S.; Takashima, Y.; Ishikawa, M. J. Med. Chem. 1984, 27, 1300. (j) Mylari, B. L.; Beyer, T. A.; Scott, P. J.; Aldinger, C. E.; Dee, M. F.; Siegel, T. W.; Zembrowski, J. J. Med. Chem. 1992, 35, 457.
27. For phthalazine and their biological importance, see: (a) Gilchrist, T. L. Heterocyclic Chemistry, 3rd ed.; Longmans: Oxford, 1997. (b) Tsoungas, P. G. ; Searcey, M. Tetrahedron Lett. 2001, 42, 6589-6592. (c) Brzezinski, J. Z.; Browski, H. B.; Epsztajn, J. Tetrahedron 1996, 52, 3261-3272. (d) Eguchi, Y.; Sasaki, F.; Takashima, Y.; Nakajima, M.; Ishikawa, M. Chem. Pharm. Bull. 1991, 39, 795. (e) Cherkez, S.; Herzig, J.; Yellin, H. J. Med. Chem. 1986, 29, 947. (f) Scheffler, G.; Engel, J.; Kutscher, B.; Sheldrick, W. S.; Bell, P. Arch. Pharm. (Weinheim) 1988, 321, 205. (g) Yamaguchi, M.; Kamei, K.; Koga, T.; Akima, M.; Kuroki, T.; Ohi, N. J. Med. Chem. 1993, 36, 4052. (h) Bavin, E. M.; Drain, D. J.; Seiler, M.; Seymour, D. E. J. Pharm. Pharmacol. 1952, 4, 844. (i) Sugimoto A.; Tanaka, H.; Eguchi, Y.; Ito, S.; Takashima, Y.; Ishikawa, M. J. Med. Chem. 1984, 27, 1300. (j) Mylari, B. L.; Beyer, T. A.; Scott, P. J.; Aldinger, C. E.; Dee, M. F.; Siegel, T. W.; Zembrowski, J. J. Med. Chem. 1992, 35, 457.
28. For phthalazine and their biological importance, see: (a) Gilchrist, T. L. Heterocyclic Chemistry, 3rd ed.; Longmans: Oxford, 1997. (b) Tsoungas, P. G. ; Searcey, M. Tetrahedron Lett. 2001, 42, 6589-6592. (c) Brzezinski, J. Z.; Browski, H. B.; Epsztajn, J. Tetrahedron 1996, 52, 3261-3272. (d) Eguchi, Y.; Sasaki, F.; Takashima, Y.; Nakajima, M.; Ishikawa, M. Chem. Pharm. Bull. 1991, 39, 795. (e) Cherkez, S.; Herzig, J.; Yellin, H. J. Med. Chem. 1986, 29, 947. (f) Scheffler, G.; Engel, J.; Kutscher, B.; Sheldrick, W. S.; Bell, P. Arch. Pharm. (Weinheim) 1988, 321, 205. (g) Yamaguchi, M.; Kamei, K.; Koga, T.; Akima, M.; Kuroki, T.; Ohi, N. J. Med. Chem. 1993, 36, 4052. (h) Bavin, E. M.; Drain, D. J.; Seiler, M.; Seymour, D. E. J. Pharm. Pharmacol. 1952, 4, 844. (i) Sugimoto A.; Tanaka, H.; Eguchi, Y.; Ito, S.; Takashima, Y.; Ishikawa, M. J. Med. Chem. 1984, 27, 1300. (j) Mylari, B. L.; Beyer, T. A.; Scott, P. J.; Aldinger, C. E.; Dee, M. F.; Siegel, T. W.; Zembrowski, J. J. Med. Chem. 1992, 35, 457.
29. For phthalazine and their biological importance, see: (a) Gilchrist, T. L. Heterocyclic Chemistry, 3rd ed.; Longmans: Oxford, 1997. (b) Tsoungas, P. G. ; Searcey, M. Tetrahedron Lett. 2001, 42, 6589-6592. (c) Brzezinski, J. Z.; Browski, H. B.; Epsztajn, J. Tetrahedron 1996, 52, 3261-3272. (d) Eguchi, Y.; Sasaki, F.; Takashima, Y.; Nakajima, M.; Ishikawa, M. Chem. Pharm. Bull. 1991, 39, 795. (e) Cherkez, S.; Herzig, J.; Yellin, H. J. Med. Chem. 1986, 29, 947. (f) Scheffler, G.; Engel, J.; Kutscher, B.; Sheldrick, W. S.; Bell, P. Arch. Pharm. (Weinheim) 1988, 321, 205. (g) Yamaguchi, M.; Kamei, K.; Koga, T.; Akima, M.; Kuroki, T.; Ohi, N. J. Med. Chem. 1993, 36, 4052. (h) Bavin, E. M.; Drain, D. J.; Seiler, M.; Seymour, D. E. J. Pharm. Pharmacol. 1952, 4, 844. (i) Sugimoto A.; Tanaka, H.; Eguchi, Y.; Ito, S.; Takashima, Y.; Ishikawa, M. J. Med. Chem. 1984, 27, 1300. (j) Mylari, B. L.; Beyer, T. A.; Scott, P. J.; Aldinger, C. E.; Dee, M. F.; Siegel, T. W.; Zembrowski, J. J. Med. Chem. 1992, 35, 457.
30. For phthalazine and their biological importance, see: (a) Gilchrist, T. L. Heterocyclic Chemistry, 3rd ed.; Longmans: Oxford, 1997. (b) Tsoungas, P. G. ; Searcey, M. Tetrahedron Lett. 2001, 42, 6589-6592. (c) Brzezinski, J. Z.; Browski, H. B.; Epsztajn, J. Tetrahedron 1996, 52, 3261-3272. (d) Eguchi, Y.; Sasaki, F.; Takashima, Y.; Nakajima, M.; Ishikawa, M. Chem. Pharm. Bull. 1991, 39, 795. (e) Cherkez, S.; Herzig, J.; Yellin, H. J. Med. Chem. 1986, 29, 947. (f) Scheffler, G.; Engel, J.; Kutscher, B.; Sheldrick, W. S.; Bell, P. Arch. Pharm. (Weinheim) 1988, 321, 205. (g) Yamaguchi, M.; Kamei, K.; Koga, T.; Akima, M.; Kuroki, T.; Ohi, N. J. Med. Chem. 1993, 36, 4052. (h) Bavin, E. M.; Drain, D. J.; Seiler, M.; Seymour, D. E. J. Pharm. Pharmacol. 1952, 4, 844. (i) Sugimoto A.; Tanaka, H.; Eguchi, Y.; Ito, S.; Takashima, Y.; Ishikawa, M. J. Med. Chem. 1984, 27, 1300. (j) Mylari, B. L.; Beyer, T. A.; Scott, P. J.; Aldinger, C. E.; Dee, M. F.; Siegel, T. W.; Zembrowski, J. J. Med. Chem. 1992, 35, 457.
31. For phthalazine and their biological importance, see: (a) Gilchrist, T. L. Heterocyclic Chemistry, 3rd ed.; Longmans: Oxford, 1997. (b) Tsoungas, P. G. ; Searcey, M. Tetrahedron Lett. 2001, 42, 6589-6592. (c) Brzezinski, J. Z.; Browski, H. B.; Epsztajn, J. Tetrahedron 1996, 52, 3261-3272. (d) Eguchi, Y.; Sasaki, F.; Takashima, Y.; Nakajima, M.; Ishikawa, M. Chem. Pharm. Bull. 1991, 39, 795. (e) Cherkez, S.; Herzig, J.; Yellin, H. J. Med. Chem. 1986, 29, 947. (f) Scheffler, G.; Engel, J.; Kutscher, B.; Sheldrick, W. S.; Bell, P. Arch. Pharm. (Weinheim) 1988, 321, 205. (g) Yamaguchi, M.; Kamei, K.; Koga, T.; Akima, M.; Kuroki, T.; Ohi, N. J. Med. Chem. 1993, 36, 4052. (h) Bavin, E. M.; Drain, D. J.; Seiler, M.; Seymour, D. E. J. Pharm. Pharmacol. 1952, 4, 844. (i) Sugimoto A.; Tanaka, H.; Eguchi, Y.; Ito, S.; Takashima, Y.; Ishikawa, M. J. Med. Chem. 1984, 27, 1300. (j) Mylari, B. L.; Beyer, T. A.; Scott, P. J.; Aldinger, C. E.; Dee, M. F.; Siegel, T. W.; Zembrowski, J. J. Med. Chem. 1992, 35, 457.
32. Parrick, J.; Ragunathan, R. J. Chem. Soc., Perkin Trans. 1 1993, 211-216.
33. Boutherin-Falson, O.; Desquand-Billiald, S.; Favrou, A.; Finet, M.; Tembo, O.; Torregrosa, J.-L.; Yannic-Arnoult, S.; PCT Int. Appl. CODEN: PIXXD2 WO 9721432 A1 19970619 CAN 127:121758 AN 1997:516337, 1997, 82 pp.
34. (a) Shaikh, I. A.; Johnson, F.; Grollman, A. P. J. Med. Chem. 1986, 29, 1329-40.
35. (b) Krapcho, A. P.; Maresch, M. J.; Helgason, A. L.; Rosner, K. E.; Hacker, M. P.; Spinelli, S.; Menta, E.; Oliva, A. J. Heterocycl. Chem. 1993, 30, 1597-1606.
36. (a) Kornblum, N.; DeLaMare, H. E. J. Am. Chem. Soc. 1951, 73, 880-881.
37. (b) Kelly, D. R.; Bansal, H.; Morgan, J. J. G. Tetrahedron Lett. 2002, 43, 9331-9333.
38. (c) Mete, E.; Altundas, R.; Secen, H.; Balci, M. Turk. J. Chem. 2003, 27, 145-153.
39. For a similar reduction, see: Dastan, A.; Saracoglu, N.; Balci, M. Eur. J. Org. Chem. 2001, 3519-3522.
40. (a) Boyd, J. D.; Foote, C. S.; Imagawa, D. K. J. Am. Chem. Soc. 1980, 102, 3641-3642.
41. (b) Sütbeyaz, Y.; Secen, H.; Balci, M. J. Org. Chem. 1988, 53, 2312-2317.
42. For the reaction of saturated bicyclic endoperoxides with CoTPP, see: Balci, M.; Akbulut, N. Tetrahedron 1985, 41, 1315-1322.
43. (a) Schenck, G. O.; Dunlap, E. D. Angew. Chem. 1956, 68, 248-249.
44. (b) Kanoko, C.; Sugimoto, A.; Tanaka, S. Synthesis 1974, 876-877.
45. Adam, W.; Balci, M. J. Am. Chem. Soc. 1979, 101, 7537-7541.
46. (c) Adam, W.; Balci, M. J. Am. Chem. Soc. 1979, 101, 7541-7547.
47. For C-C cleavage of the endoperoxides upon threatment with CoTPP or thermolysis reactions, see: (a) Özer, G.; Saraçoǧlu, N.; Balci, M. Heterocycles 2000, 53, 761-764. (b) Sengul, M. E.; Simsek, N.; Balci, M. Eur. J. Org. Chem. 2000, 1359-1363. (c) Hathaway, S. H.; Paquette, L. A. Tetrahedron 1985, 41, 2037-2043. (d) Paquette, L. A.; Carr, R. V. C.; Arnold, E.; Clardy, J. J. Org. Chem. 1980, 45, 4907-4913.
48. For C-C cleavage of the endoperoxides upon threatment with CoTPP or thermolysis reactions, see: (a) Özer, G.; Saraçoǧlu, N.; Balci, M. Heterocycles 2000, 53, 761-764. (b) Sengul, M. E.; Simsek, N.; Balci, M. Eur. J. Org. Chem. 2000, 1359-1363. (c) Hathaway, S. H.; Paquette, L. A. Tetrahedron 1985, 41, 2037-2043. (d) Paquette, L. A.; Carr, R. V. C.; Arnold, E.; Clardy, J. J. Org. Chem. 1980, 45, 4907-4913.
49. For C-C cleavage of the endoperoxides upon threatment with CoTPP or thermolysis reactions, see: (a) Özer, G.; Saraçoǧlu, N.; Balci, M. Heterocycles 2000, 53, 761-764. (b) Sengul, M. E.; Simsek, N.; Balci, M. Eur. J. Org. Chem. 2000, 1359-1363. (c) Hathaway, S. H.; Paquette, L. A. Tetrahedron 1985, 41, 2037-2043. (d) Paquette, L. A.; Carr, R. V. C.; Arnold, E.; Clardy, J. J. Org. Chem. 1980, 45, 4907-4913.
50. For C-C cleavage of the endoperoxides upon threatment with CoTPP or thermolysis reactions, see: (a) Özer, G.; Saraçoǧlu, N.; Balci, M. Heterocycles 2000, 53, 761-764. (b) Sengul, M. E.; Simsek, N.; Balci, M. Eur. J. Org. Chem. 2000, 1359-1363. (c) Hathaway, S. H.; Paquette, L. A. Tetrahedron 1985, 41, 2037-2043. (d) Paquette, L. A.; Carr, R. V. C.; Arnold, E.; Clardy, J. J. Org. Chem. 1980, 45, 4907-4913.
51. (a) Mori, A.; Takeshita, H. Chem. Lett. 1978, 395-396.
52. (b) Kende A. S.; Chu, J. Y. C. Tetrahedron Lett. 1970, 11, 4837-4840.
53. (c) Adam, W.; Balci, M. Angew. Chem. 1978, 90, 1014-1015.